Phoebe Huang

Cooley advised Kimia Therapeutics on its $55 million Series A financing. Partner Josh Seidenfeld led the Cooley team advising Kimia Therapeutics, which is a drug discovery platform that uncovers novel biological insights through precision chemistry and machine learning.

Read more

Cooley advised Titan Flood, an artificial intelligence-based, next-generation cloud native platform providing residential flood insurance, on its strategic investment from K2 Insurance Services.

Cooley advised Helion Energy, a clean energy company committed to creating a new era of plentiful, zero-carbon electricity from fusion, on its $500 million Series E financing round, which also includes an opportunity for an additional $1.7 billion tied to Helion reaching key performance milestones. Lawyers Sonya Erickson, Colleen Badgley, Ashley Brown, Justine Chiu and Jasjit Grewal led the Cooley team advising Helion.

Cooley advised Accolade on its offering of $287.5 million principal amount of 0.50% convertible senior notes due 2026. Accolade, whose securities trade on the Nasdaq Global Select Market  under the symbol ACCD, is a provider of personalized, technology-enabled solutions that help people to understand, navigate and utilize the healthcare system and their workplace benefits.Partners Mischi a Marca, Alan Hambelton, John Robertson, and Jason Savich led the Cooley team.

Cooley advised the underwriters on J2 Global’s offering of $750 million aggregate principal amount of 4.625% convertible notes due 2030 in a private placement to qualified institutional buyers. Barclays Bank and Goldman Sachs acted as book-running managers for the offering. J2 Global, whose securities trade on the Nasdaq Global Select Market under the symbol “JCOM,” is a leading web-based communications and cloud services platform. Partners Mike Tollini, Mischi a Marca and Alan Hambelton led the Cooley team advising the underwriters.